Lingling Li - Publications

Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study.

Journal: BMC cancer

Published: September 05, 2023

A new risk predictive scoring system of vasovagal reactions in patients with preoperative autologous blood donation.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: April 21, 2023

Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis.

Journal: BMC cancer

Published: April 07, 2023

Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases.

Journal: Frontiers in oncology

Published: November 29, 2022

Effects on neuromodulation, acupuncture, and aerobic exercises on migraine and tension-type headache outcomes: A systematic review and meta-analysis.

Journal: Medicine

Published: November 18, 2022

Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer.

Journal: Frontiers in pharmacology

Published: June 13, 2022

Systems Metabolic Engineering of Escherichia coli Coculture for De Novo Production of Genistein.

Journal: ACS synthetic biology

Published: May 04, 2022

The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors.

Journal: Frontiers in oncology

Published: March 01, 2022

Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma.

Journal: American journal of translational research

Published: July 14, 2021

Microbial synthesis of plant polyphenols

Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology

Published: July 06, 2021

Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.

Journal: Medicine

Published: June 22, 2021

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy.

Journal: Frontiers in oncology

Published: April 20, 2021